(Q44336891)

2 December 2017

title

Buprenorphine 101: treating opioid dependence with buprenorphine in an office-based setting (English)

1 reference

2 December 2017

0 references

Matthew Torrington

1

1 reference

2 December 2017

Catherine P Domier

series ordinal

2

1 reference

2 December 2017

Maureen Hillhouse

series ordinal

3

1 reference

2 December 2017

Walter Ling

series ordinal

4

1 reference

2 December 2017

publication date

1 January 2007

1 reference

Journal of Addictive Diseases

2 December 2017

published in

1 reference

2 December 2017

volume

26

1 reference

2 December 2017

issue

3

1 reference

2 December 2017

page(s)

93-99

1 reference

The practice of office-based buprenorphine treatment of opioid dependence: is it associated with new patients entering into treatment?

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1300%2FJ069V26N03_10

Bringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V26N03_10

Characterizing the emerging population of prescription opioid abusers

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V26N03_10

Buprenorphine treatment of heroin dependence (detoxification and maintenance) in a private practice setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V26N03_10

Methadone maintenance in primary care: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V26N03_10

Buprenorphine for opiate addiction: potential economic impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V26N03_10

Office-based primary care physicians called on to treat the "new" addict

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V26N03_10

Treating opioid dependence. Growing implications for primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V26N03_10

Buprenorphine for office-based practice: consensus conference overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V26N03_10

Safety and health policy considerations related to the use of buprenorphine/naloxone as an office-based treatment for opiate dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V26N03_10

Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V26N03_10

21 January 2018

Identifiers

DOI

10.1300/J069V26N03_10

1 reference

2 December 2017

1 reference